Abstract
Resurfacing (RA) and total hip arthroplasty (THA) are options in the treatment of debilitating hip pathology. 381 patients that had undergone arthroplasty with a BHR RA, ASR RA, metal-on-metal (MOM) THA or ceramic-on-ceramic (CoC) THA were reviewed for satisfaction, function, health and survivorship at a median follow up of 50 months. Significantly lower survivorship for revision and reoperation was observed in the ASR group. The BHR and CoC demonstrated better outcome scores than the ASR (OHS and SAPS) and the BHR better scores than the MoM (OHS and SF12 PCS). In the short to medium term, survivorship and outcomes for the best performing RA (BHR) and THA (CoC) were comparable. There was a non-significant trend towards poorer outcome scores in the MoM THA group. (C) 2013 Elsevier Inc. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 842-848 |
Number of pages | 7 |
Journal | Journal of Arthroplasty |
Volume | 28 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2013 |
Research Groups and Themes
- Centre for Surgical Research
Keywords
- arthroplasty
- hip
- treatment outcome
- survival rate
- 1ST 230 HIPS
- SURFACE ARTHROPLASTY
- UNITED-STATES
- METAL
- OSTEOARTHRITIS
- REPLACEMENT
- 5-YEAR
- TRIAL
- SINGLE
- DEBRIS